Drug
Gen1057
Gen1057: highest development phase Phase 1, developed by Genmab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Genmab
Trials
| Drug | Phase | Indication |
|---|---|---|
| GEN1057 NCT06573294 | Phase 1 | Advanced Malignant Solid Tumors |
Latest
No recent events.
Follow Gen1057 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.